AzTrials
AzTrials

Lateral EpicondylitisNCT07042997

Anatomical Accuracy of Palpation-Guided Dry Needling in Lateral Epicondylitis

A study testing Palpation-Guided Dry Needling With Ultrasound Verification in people with Lateral Epicondylitis, run by nurmuhammet tas at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective study evaluated the anatomical accuracy of palpation-guided dry needling in patients with lateral epicondylitis using ultrasound verification. The study included 39 participants aged 18-70 years with lateral elbow pain lasting at least six weeks and at least one active myofascial trigger point in the… Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Lateral Epicondylitis
What is being tested?
Palpation-Guided Dry Needling With Ultrasound Verification
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
39 participants
Where
1 siteTurkey (Türkiye)
Study dates
24 Jun 2025to 30 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18-70 years.
  • Lateral elbow pain lasting at least 6 weeks.
  • Diagnosis of lateral epicondylitis confirmed by magnetic resonance imaging (MRI).
  • Presence of at least one active myofascial trigger point in the extensor digitorum communis (EDC), extensor carpi radialis brevis (ECRB), extensor carpi radialis longus (ECRL), or brachioradialis (BR) muscle, identified by physical examination.
  • Provision of written informed consent before participation.

Who cannot join

  • Peripheral neuropathy.
  • Cervical radiculopathy.
  • Coagulopathy.
  • Active local or systemic infection.
  • Inflammatory arthritis.
  • Impaired skin integrity at the needling site.
  • Metal implants in the application area.
  • Other conditions expected to affect muscle volume or tissue integrity.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Basaksehir Cam and Sakura City Hospital

    Istanbul, Istanbul, 34480

Other trials in Turkey (Türkiye)

About this study

Official title: Anatomical Accuracy of Palpation-Guided Dry Needling in Lateral Epicondylitis: An Ultrasound-Verified Study of Forearm Extensor Muscles

This prospective study evaluated the anatomical accuracy of palpation-guided dry needling in patients with lateral epicondylitis using ultrasound verification. The study included 39 participants aged 18-70 years with lateral elbow pain lasting at least six weeks and at least one active myofascial trigger point in the forearm extensor muscles.

The target muscle was selected based on the lowest pressure pain threshold among the evaluated muscles. Dry needling was performed using anatomical landmarks and palpation without real-time ultrasound guidance. Immediately after needle placement, an independent ultrasound assessor, blinded to the intended target muscle, identified the actual location of the needle tip.

The primary outcome was the proportion of correctly placed needles in the intended target muscle. Accuracy was evaluated separately for the brachioradialis, extensor carpi radialis brevis, extensor carpi radialis longus, and extensor digitorum communis muscles.

Read the detailed description

Study Design and Muscle Selection

This prospective, single-center anatomical accuracy study was conducted in patients with lateral epicondylitis. The study evaluated the accuracy of palpation-guided dry needling targeting four forearm muscles: extensor digitorum communis (EDC), extensor carpi radialis brevis (ECRB), extensor carpi radialis longus (ECRL), and brachioradialis (BR).

Patients underwent clinical examination to identify active myofascial trigger points (MTrPs). When active MTrPs were identified in more than one muscle, pressure pain thresholds were measured using a digital algometer (FPX 25, Wagner Instruments) with a 1 cm² probe. The muscle with the lowest pressure pain threshold was selected for dry needling. Target-muscle selection was not randomized, and each participant underwent needling of one selected muscle.

During algometric assessment, ultrasound was used to verify that the algometer probe was positioned over the intended muscle rather than an adjacent muscle. Ultrasound was not used to guide needle insertion. A minimum interval of 10 minutes was maintained between algometric assessment and dry needling.

Palpation-Guided Dry Needling Procedure

All dry needling procedures were performed by a single experienced physician using palpation and anatomical landmarks without real-time ultrasound guidance. Patients were positioned supine, and the skin was sterilized before needle insertion.

A Hua-Long 0.30 × 30 mm single-use sterile acupuncture needle was used. The insertion site and direction were determined according to the anatomical characteristics of the selected muscle. Needle insertion depth was limited to 20 mm for EDC and ECRB and 15 mm for ECRL and BR.

Ultrasound Verification of Needle Placement

Immediately after needle insertion, an independent sonographer with 10 years of experience in musculoskeletal ultrasonography evaluated needle-tip placement using a high-frequency linear ultrasound probe (5-12 MHz; Clarius, Canada).

The sonographer was not informed of the intended target muscle before anatomical verification. However, the skin entry point, patient positioning, and needle trajectory were visible during the assessment.

The needle tip was identified using direct ultrasound visualization in transverse and longitudinal planes. Muscle identification was based on anatomical landmarks, including the radius, adjacent extensor muscles, and intermuscular fascial boundaries.

The ultrasound-confirmed anatomical location was documented separately and communicated to the needling physician, who compared it with the intended target muscle. Placement was classified as correct when the needle tip was visualized within the intended muscle and incorrect when it was located in another anatomical structure.

Conservative Management

After completion of dry needling and ultrasound verification, all participants received standard conservative management consisting of a wrist splint for two weeks and a home exercise program involving daily eccentric strengthening and stretching of the wrist extensor muscles (3 sets of 10 repetitions per day for two weeks).

Conservative treatment was initiated after anatomical accuracy assessment and therefore did not influence the primary outcome.

Primary Outcome

The primary outcome was anatomical needle-placement accuracy, defined as the proportion of needling procedures in which the needle tip was correctly located within the intended target muscle, as verified by ultrasound. Accuracy was evaluated separately for EDC, ECRB, ECRL, and BR.

Being tested
Palpation-Guided Dry Needling With Ultrasound Verification
Keywords
lateral epicondylitis, dry needling, trigger point, ultrasound verification, forearm extensors, myofascial trigger point, anatomical accuracy
Medical subject headings
Tennis Elbow

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Palpation-Guided Dry Needling With Ultrasound VerificationProcedure or surgery

    A single experienced physician performed palpation-guided dry needling of one selected forearm muscle (EDC, ECRB, ECRL, or BR) using a sterile Hua-Long 0.30 × 30 mm acupuncture needle. The target muscle was selected according to the lowest pressure pain threshold. Ultrasound was used to confirm algometer positioning before needling but was not used to guide needle insertion. Following a minimum 10-minute interval after algometric assessment, dry needling was performed using anatomical landmarks and palpation. Immediately after needle insertion, an independent sonographer, unaware of the intended target muscle, identified the needle-tip location using a 5-12 MHz linear ultrasound probe. Placement was classified as correct or incorrect according to whether the needle tip was located within the intended target muscle.

Study groups in NCT07042997
Study groupRoleWhat they receive
Palpation-Guided Dry Needling With Ultrasound VerificationExperimentalParticipants with MRI-confirmed lateral epicondylitis and at least one active myofascial trigger point underwent palpation-guided dry needling of one forearm muscle selected according to the lowest pressure pain threshold. Immediately after needle insertion, an independent ultrasound assessor verified the anatomical location of the needle tip. Ultrasound was not used to guide needle insertion.
Receives: Procedure: Palpation-Guided Dry Needling With Ultrasound Verification

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anatomical Accuracy of Palpation-Guided Dry Needling

    Anatomical needle-placement accuracy was assessed by ultrasound verification immediately after palpation-guided dry needling. Placement was classified as correct when the needle tip was visualized within the intended target muscle and incorrect when it was located outside the intended muscle. The proportion of correctly placed needles was calculated separately for the brachioradialis (BR), extensor digitorum communis (EDC), extensor carpi radialis brevis (ECRB), and extensor carpi radialis longus (ECRL) muscles.

    Measured: Immediately after needle insertion, during the same study visit.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2025
  2. Study start24 Jun 2025
  3. Primary completion30 Jul 2025
  4. Study completion30 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Model description
All participants underwent palpation-guided dry needling of one target forearm muscle selected according to the lowest pressure pain threshold. Needle placement was subsequently verified using ultrasound by an independent assessor. Participants were not randomized, and there were no separate intervention or control groups.
Masking
None (open label)
Enrolment
39 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07042997
Sponsor's protocol ID
ErzurumNMT
Status last verified
Oct 2026
First submitted
20 Jun 2025
Last updated
26 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared publicly due to participant confidentiality and data privacy considerations. Only aggregated, anonymized study results will be reported in the publication.

Questions about this trial

What is this clinical trial studying?

A study testing Palpation-Guided Dry Needling With Ultrasound Verification in people with Lateral Epicondylitis, run by nurmuhammet tas at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anatomical Accuracy of Palpation-Guided Dry Needling (time frame: Immediately after needle insertion, during the same study visit.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in